Fenofibrate: A Review of its Lipid-Modifying Effects in Dyslipidemia and its Vascular Effects in Type 2 Diabetes Mellitus

Author： Keating Gillian M.

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.11, Iss.4, 2011-08, pp. : 227-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fenofibrate: A Review of its Use in Primary Dyslipidaemia, the Metabolic Syndrome and Type 2 Diabetes Mellitus

By Keating Gillian M. Croom Katherine F.

Drugs, Vol. 67, Iss. 1, 2007-01 ,pp. : 121-153

Adis International

Access to resources Recommend Favorite

Cilostazol: beneficial lipid effects in IGT/type 2 diabetes mellitus

Inpharma, Vol. 1, Iss. 1293, 2001-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Troglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Plosker G.L. Faulds D.

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 409-438

Adis International

Access to resources Recommend Favorite

Repaglinide: A Pharmacoeconomic Review of its Use in Type 2 Diabetes Mellitus

By Plosker G.L. Figgitt D.P.

PharmacoEconomics, Vol. 22, Iss. 6, 2004-01 ,pp. : 389-411

Adis International

Access to resources Recommend Favorite

Rosiglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Wagstaff A.J. Goa K.L.

Drugs, Vol. 62, Iss. 12, 2002-01 ,pp. : 1805-1837

Adis International

Access to resources Recommend Favorite